Antifibrotic Shows Mixed Results in RA-ILD Antifibrotic Shows Mixed Results in RA-ILD

Adding pirfenidone did not change decline in forced vital capacity or mortality risk, but may slow rate of lung function decline.MDedge News
Source: Medscape Rheumatology Headlines - Category: Rheumatology Tags: Pulmonary Medicine News Source Type: news
More News: Rheumatology